Summary ICRWorld's Cancer Biomarker market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players. Global Cancer Biomarker Market: Product Segment Analysis "Based on biomarker type: Protein Biomarkers Genetic Biomarkers Others (Cell, Viral, and Carbohydrate Biomarkers) " "Based on tumor type: Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Cervical Cancer " Others (Gastrointestinal stromal tumors (GIST), Lung, Ovarian, bladder, Pancreatic, Kidney, Melanoma, and Leukemia) Global Cancer Biomarker Market: Application Segment Analysis Diagnostics Drug Discovery and Development Prognostics Risk Assessment Others (Personalized Medicine, Surrogate endpoints, Recurrence, and Therapeutics) Global Cancer Biomarker Market: Regional Segment Analysis USA Europe Japan China India South East Asia The Players mentioned in our report Abbott Laboratories Affymetrix, Inc. Qiagen Roche Diagnostics Ltd. Agilent Technologies, Inc. Quest Diagnostics Inc. Merck & Co. Inc. Hologic, Inc. Becton, Dickinson and Company Illumina, Inc.
Table of Content Chapter 1 About the Cancer Biomarker Industry 1.1 Industry Definition and Types "1.1.1 Based on biomarker type: Protein Biomarkers Genetic Biomarkers Others (Cell, Viral, and Carbohydrate Biomarkers) " "1.1.2 Based on tumor type: Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Cervical Cancer " 1.1.3 Others (Gastrointestinal stromal tumors (GIST), Lung, Ovarian, blad
